AMAPKPpar-γ/NF-κB退

Tao Xu1, Hongqi Zhao1, Xuan Fang1

  • 1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

概括

穆尔贝罗西德A (MA) 通过减少炎症和保持磁盘结构,有效地治疗椎间盘退化 (IVDD). 它通过抑制MAPK和NF-κB通路,可能通过Ppar-γ激活来起作用,为IVDD提供了一个有前途的治疗途径.